| Protease-activated receptor 2: a promising therapeutic target for women's cancers H Shah, DP Fairlie, J Lim Journal of Pharmacology and Experimental Therapeutics, 2024 | | 2024 |
| Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells H Shah, TA Hill, J Lim, DP Fairlie Journal of Cell Communication and Signaling 17 (4), 1293-1307, 2023 | 1 | 2023 |
| Venom composition and bioactive RF-amide peptide toxins of the saddleback caterpillar, Acharia stimulea (Lepidoptera: limacodidae) MH Goudarzi, DA Eagles, J Lim, KA Biggs, AC Kotze, AP Ruffell, ... Biochemical Pharmacology 213, 115598, 2023 | 2 | 2023 |
| Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages KC Wu, ND Condon, TA Hill, RC Reid, DP Fairlie, J Lim Journal of Innate Immunity 15 (1), 468-484, 2023 | 3 | 2023 |
| Modifying a Hydroxyl Patch in Glucagon-like Peptide 1 Produces Biased Agonists with Unique Signaling Profiles P Wang, TA Hill, J Mitchell, RL Fitzsimmons, W Xu, Z Loh, JY Suen, J Lim, ... Journal of Medicinal Chemistry 65 (17), 11759-11775, 2022 | 4 | 2022 |
| Tuning electrostatic and hydrophobic surfaces of aromatic rings to enhance membrane association and cell uptake of peptides AD de Araujo, HN Hoang, J Lim, JYW Mak, DP Fairlie Angewandte Chemie 134 (29), e202203995, 2022 | 17 | 2022 |
| Temporal perturbation of histone deacetylase activity reveals a requirement for HDAC1–3 in mesendoderm cell differentiation E Sinniah, Z Wu, S Shen, M Naval-Sanchez, X Chen, J Lim, A Helfer, ... Cell Reports 39 (7), 2022 | 1 | 2022 |
| The histone deacetylase Hdac7 supports LPS-inducible glycolysis and Il-1β production in murine macrophages via distinct mechanisms D Ramnath, K Das Gupta, Y Wang, R Abrol, JEB Curson, J Lim, RC Reid, ... Journal of Leukocyte Biology 111 (2), 327-336, 2022 | 9 | 2022 |
| Chemical Biology AD de Araujo, J Lim, KC Wu, HN Hoang, HT Nguyen, DP Fairlie | | 2022 |
| Helical structure in cyclic peptides: effect of N-methyl amides versus esters C Wu, HN Hoang, TA Hill, J Lim, WM Kok, K Akondi, L Liu, DP Fairlie Chemical Communications 58 (89), 12475-12478, 2022 | 3 | 2022 |
| Landscaping macrocyclic peptides: stapling hDM2-binding peptides for helicity, protein affinity, proteolytic stability and cell uptake AD de Araujo, J Lim, KC Wu, HN Hoang, HT Nguyen, DP Fairlie RSC Chemical Biology 3 (7), 895-904, 2022 | 13 | 2022 |
| HDAC7 inhibition by phenacetyl and phenylbenzoyl hydroxamates JYW Mak, KC Wu, PK Gupta, S Barbero, MG McLaughlin, AJ Lucke, J Tng, ... Journal of Medicinal Chemistry 64 (4), 2186-2204, 2021 | 15 | 2021 |
| PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR Y Jiang, J Lim, KC Wu, W Xu, JY Suen, DP Fairlie British Journal of Pharmacology 178 (4), 913-932, 2021 | 25 | 2021 |
| Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition AJ Kennedy, L Sundström, S Geschwindner, EKY Poon, Y Jiang, R Chen, ... Communications biology 3 (1), 782, 2020 | 27 | 2020 |
| Achiral derivatives of hydroxamate AR-42 potently inhibit HDAC1 and cancer cell proliferation A Lucke, KC Wu, J Tng, R Reid, J Lim, W Xu, D Fairlie American Chemical Society SciMeetings 1 (2), 2020 | | 2020 |
| Achiral derivatives of hydroxamate AR-42 potently inhibit class I HDAC enzymes and cancer cell proliferation J Tng, J Lim, KC Wu, AJ Lucke, W Xu, RC Reid, DP Fairlie Journal of medicinal chemistry 63 (11), 5956-5971, 2020 | 21 | 2020 |
| Potent thiophene antagonists of human complement C3a receptor with anti-inflammatory activity JA Rowley, RC Reid, EKY Poon, KC Wu, J Lim, RJ Lohman, JK Hamidon, ... Journal of Medicinal Chemistry 63 (2), 529-541, 2020 | 20 | 2020 |
| Heterocycles for switching GPCR ligand conformation and activity D Fairlie, R Reid, J Rowley, KC Wu, MK Yau, J Lim, A Iyer Abstracts of Papers of the American Chemical Society 257, 2019 | | 2019 |
| Chemical synthesis and applications of a novel fluorescent probe for human complement C3a receptor C Wu, A de Araujo, KC Wu, R Reid, T Durek, J Lim, D Fairlie ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |
| Bicyclic helical peptides as dual inhibitors selective for Bcl2A1 and Mcl-1 proteins A D. de Araujo, J Lim, KC Wu, Y Xiang, AC Good, R Skerlj, DP Fairlie Journal of medicinal chemistry 61 (7), 2962-2972, 2018 | 46 | 2018 |
David P FairlieProfessor, University of Queensland在 imb.uq.edu.au 的电子邮件经过验证
